as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
3.94%
Downside
1.25%
Upside
52 Week's Low
52 Week's High
80.29%
Downside
80.65%
Upside
Check Immuneering Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$350.3M
EPS (TTM)
-1.602
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.67
Industry PE ratio
0PEG Ratio
0EBITDA
-63.7M
Revenue (TTM)
455.0
Profit Margin
0.00%
Return On Equity TTM
46271000.00%
Track how Immuneering Corp P/E has moved over time to understand its valuation trends.
Immuneering Corp in the last 5 years
Lowest (-6.47x)
December 31, 2021
Industry (0.00x)
October 18, 2025
Today (-0.67x)
October 18, 2025
Highest (-0.71x)
June 30, 2025
Today’s Price to Earnings Ratio: -0.67x
Compare market cap, revenue, PE, and other key metrics of Immuneering Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $350.3M | NA | -0.67 | 0.00% | |
BUY | $63.1B | 231.27% | -505.15 | -12.96% | |
NA | $36.7B | NA | NA | -3.89% | |
BUY | $104.8B | 91.13% | 29.04 | 31.86% | |
BUY | $60.3B | -3.62% | 14.35 | 31.37% |
The Immuneering Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Immuneering Corp investment value today
Current value as on today
₹2,53,902
Returns
₹1,53,902
(+153.9%)
Returns from Immuneering Corp Stock
₹1,49,107 (+149.11%)
Dollar Returns*
₹4,794 (+4.79%)
Based on 14 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Immuneering Corp. Average target price of $16.6
Get share price movements and forecasts by analysts on Immuneering Corp.
What analysts predicted
66.39%UPSIDE
Target Price
$16.6
Current Price
$5.58
Analyzed by
14 Analysts
Target
$16.60
Immuneering Corp target price $16.6, a slight upside of 66.39% compared to current price of $5.58. According to 14 analysts rating.
Search interest for Immuneering Corp Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 30 September
Tue, 09:12 PM
-Mizuho reaffirms Outperform rating for Immuneering, maintaining $10 price target after positive Phase 2a trial results.
Wed, 07:52 AM
-Director Peter Feinberg invests $35,900 in Immuneering, reflecting confidence amid significant public offering and promising clinical trial data.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, -18.05M → -14.43M (in $), with an average increase of 12.1% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, -94.41M → 726.32K (in $), with an average increase of 13099.5% per quarter
Best in 1 Year
In the last 1 year, IMRX has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 150.9% return, outperforming this stock by 208.4%
Price Dip
In the last 7 days, IMRX stock has moved down by -9.0%
Organisation | Immuneering Corp |
Headquarters | 245 Main Street, Cambridge, MA, United States, 02142 |
CEO | Dr. Benjamin J. Zeskind M.B.A., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Robert J. Carpenter M.B.A., M.S. | Co-Founder & Chair Emeritus |
Dr. Brett M. Hall Ph.D. | Chief Scientific Officer |
Ms. Mallory Morales CPA | Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer |
Ms. Leah R. Neufeld | Chief People Officer |
Dr. Benjamin J. Zeskind M.B.A., Ph.D. | Co-Founder, President, CEO & Director |
Mr. Michael D. Bookman J.D. | Chief Legal Officer & Secretary |
Ms. Paula George CPA | Director of Accounting & Operations and Assistant Corporate Controller |
Dr. Peter King Ph.D. | Head of Discovery & VP |
Dr. Praveen Nair Ph.D. | Head of Translational Pharmacology & VP |
Mr. Harold E. Brakewood | Chief Business Officer |
Immuneering Corp share price today is $5.58 as on at the close of the market. Immuneering Corp share today touched a day high of $5.65 and a low of $5.36.
Immuneering Corp share touched a 52 week high of $10.08 on and a 52 week low of $1.1 on . Immuneering Corp stock price today i.e. is closed at $5.58,which is 44.64% down from its 52 week high and 407.27% up from its 52 week low.
Immuneering Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Immuneering Corp (IMRX) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Immuneering Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Immuneering Corp share’s latest price of $5.58 as on October 18, 2025 at 1:29 am IST, you will get 1.7921 shares of Immuneering Corp. Learn more about
fractional shares .